Advanced Clinical Solutions for WAIS-IV and WMS-IVc.ymcdn.com/sites/ · PDF fileAdvanced...
Transcript of Advanced Clinical Solutions for WAIS-IV and WMS-IVc.ymcdn.com/sites/ · PDF fileAdvanced...
1Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
Advanced Clinical Solutions Advanced Clinical Solutions for WAISfor WAIS--IV and WMSIV and WMS--IVIV
Gloria Maccow, PhDAssessment Training Consultant
2 | Copyright © 2013. All rights reserved.
AgendaAgenda
• Describe components of Advanced Clinical Solutions for WAIS-IV and WMS-IV (ACSW4W4).
• Select components of ACSW4W4 to answer specific referral questions;
• Analyze data from ACSW4W4 to determine if cognitive abilities are declining; and
• Analyze data from ACSW4W4 to determine if examinee’s performance is consistent with the nature of the injury or clinical condition.
2Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
Advanced Clinical Solutionsfor WAIS-IV and WMS-IV
is an individually administered array of tests, procedures, and scores
addressing specific clinical questions and needs.
4 | Copyright © 2013. All rights reserved.
Primary Goal of ACS . . .Primary Goal of ACS . . .
To expand and enhance the clinical utility of WAIS-IV and/or WMS-IV through . . .
3Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
5 | Copyright © 2013. All rights reserved.
Applications of ACS . . .Applications of ACS . . .
additional assessments of:
– premorbid functioning– effort– social cognition– executive function
A separate instrument, Texas Functional Living Scale, linked with the WAIS-IV and WMS-IV, can be used to assess instrumental activities of daily living.
6 | Copyright © 2013. All rights reserved.
Applications of ACS . . .Applications of ACS . . .
and software that delivers:
– Demographically Adjusted Norms– Additional scores for WAIS-IV and WMS-IV– Reliable Change scores
4Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
7 | Copyright © 2013. All rights reserved.
Designed for Use . . .Designed for Use . . .
• in forensic settingsforensic settings to measure pre-morbid function (insurance claims) and suboptimal effort (malingering).
• with older adultsolder adults to assess current status, premorbid functioning, decline in cognitive functions, and reliable change.
8 | Copyright © 2013. All rights reserved.
Designed for Use . . .Designed for Use . . .
• with individuals who have traumatic brain traumatic brain injuryinjury to assess premorbid functioning, executive functions, and social cognition.
• with individuals with Autism/ Autism/ AspergerAsperger’’ssto evaluate social cognition.
5Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
9 | Copyright © 2013. All rights reserved.
Components of ACSComponents of ACS
Memory GridCardsWord Choice Stimulus BookRecord Forms/Booklets
Additional Assessments
6Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
11 | Copyright © 2013. All rights reserved.
PremorbidPremorbid FunctioningFunctioning
Test of Pre-Morbid Functioning (TOPF)
ʊ Revision of the Wechsler Test of Adult Reading (WTAR).
ʊ Provides an estimate of premorbidintellectual functioning.
12 | Copyright © 2013. All rights reserved.
PremorbidPremorbid FunctioningFunctioning
Test of Pre-Morbid Functioning (TOPF)
– Revised and re-normed with WAIS–IV and WMS–IV.
ʊ Enhanced by the addition of more difficult words and an extended IQ range of predictability.
7Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
13 | Copyright © 2013. All rights reserved.
Test of Test of PremorbidPremorbid FunctioningFunctioning
• Uses Atypical Grapheme-Phoneme translation to measure word knowledge through reading.
• Relatively resistant to brain injury and dementia.
14 | Copyright © 2013. All rights reserved.
Test of Test of PremorbidPremorbid FunctioningFunctioning
Premorbid Prediction Models– Demographics only (simple or complex)– TOPF only– Demographics with TOPF
Predict WAIS-IV Indexes and WMS-IV IMI, DMI, and VWMI
8Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
15 | Copyright © 2013. All rights reserved.
EffortEffort
Assessing Suboptimal Effort
— Help determine if the examinee’s level performance is consistent with the nature of his or her injury or clinical condition.
— Information on effort may be required for certain medical-legal and forensic evaluations.
16 | Copyright © 2013. All rights reserved.
EffortEffort
Assessing Suboptimal Effort• Available for Ages 16-69• External Measure
ʊ New subtest: Word Choice
• Embedded Measuresʊ Reliable Digit Spanʊ Logical Memory Recognitionʊ Verbal Paired Associates Recognitionʊ Visual Reproduction Recognition
9Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
17 | Copyright © 2013. All rights reserved.
Social CognitionSocial Cognition
Assessing Social Cognition
ʊ An assessment of an individual’s ability to understand non-verbal communication and social interactions.
ʊ Three new subtests (Social Perception, Faces -Supplemental, Names - Supplemental) provide assessments of emotion, face, and name recognition, as well as prosody and incidental recall of emotional expression. Audio files on CD-ROM.
18 | Copyright © 2013. All rights reserved.
Social Perception SubtestSocial Perception Subtest
Consists of 3 tasks– Affect Naming (Happy, Sad, Angry, Surprise,
Disgust, Fear, and Neutral)
– Prosody-Face Matching (includes Sarcasm)
– Prosody-Pairs Matching
� Listen to a pair of individuals interacting.
� Describe how tone of voice changes the meaning of what is said.
10Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
19 | Copyright © 2013. All rights reserved.
Executive FunctionExecutive Function
Assessing Executive Function with selected tests from Delis-Kaplan Executive Function System (D-KEFS)
Trail Making (Conditions 2, 3, & 4)ɔ Number Sequencing, Letter Sequencing, Number-
Letter Switching
Verbal Fluency
ɔ Letter and Category Fluency, Category Switching
Now correlated with WAIS–IV and WMS–IV
20 | Copyright © 2013. All rights reserved.
Verbal FluencyVerbal Fluency
Note- this is a language test. Deficits in executive functioning may be inferred if no significant language impairments are present.
11Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
21 | Copyright © 2013. All rights reserved.
Instrumental Activities of Instrumental Activities of Daily LivingDaily Living
22 | Copyright © 2013. All rights reserved.
About TFLSAbout TFLS
TFLS is a brief, ecologically valid, performance based measure to identify the level of care required by an individual.
Authors: Munro Cullum, PhD, Myron F. Weiner, MD, and Kathleen C. Saine, PhD.
Publication Date: April 2009
12Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
23 | Copyright © 2013. All rights reserved.
Overview of TFLSOverview of TFLS
• Brief assessment of functional competenceʊ 15 minutes to administerʊ Assesses Instrumental Activities of Daily Living
(IADL)
• Performance-based measureʊ Direct assessment of skills
• Designed for Ages 16-90
24 | Copyright © 2013. All rights reserved.
Use TFLS to . . . Use TFLS to . . .
– Assess functional abilities (Time, Money and Calculation Skills, Communication, Memory)
– Screen for dementia– Monitor functional decline– Monitor treatment/drug efficacy– Determine level of care required
Linked with WAIS-IV and WMS-IV
13Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
25 | Copyright © 2013. All rights reserved.
Interpretation of TFLSInterpretation of TFLSTotal Score T-Score metric combines all 4 domains.
– T-Score above 40 points suggests individual can live independently.
– T-Score below 25 points often suggests individual may need to reside in a special care unit.
– T-score of 26-40 (mild, mild-to-moderate, and moderate impairment) suggests individual may need partial or fully assisted living.
ACS SoftwareAdditional Scores
14Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
27 | Copyright © 2013. All rights reserved.
Demographically Adjusted NormsDemographically Adjusted Norms
• Enable clinician to refine hypothesis about the degree to which a specific score is unexpected when compared to individuals of similar background characteristics (e.g., education level).
• Norms approximate the unique demographic subgroup of an individual.
28 | Copyright © 2013. All rights reserved.
Demographically Adjusted NormsDemographically Adjusted Norms
Available for WAIS-IV and WMS-IV Subtest and Index Scores
ɔ Education-only adjusted norms
ɔ Full Demographically adjusted norms
15Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
29 | Copyright © 2013. All rights reserved.
Use of Demographically Use of Demographically Adjusted NormsAdjusted Norms
• Meant to minimize the impact of psychosocial variables on the diagnosis of cognitive impairment, such as estimating the degree of cognitive impairment after a brain injury or insult.
• “. . . most appropriately applied in the context of a neurodiagnosticassessment.”
30 | Copyright © 2013. All rights reserved.
Use of Demographically Use of Demographically Adjusted NormsAdjusted Norms
NOT a replacement or substitute for WAIS-IV or WMS-IV conventional age-adjusted norms. NOT to be used for:
9 psychoeducational evaluations,
9 determination of intellectual deficiency,
9 vocational assessment,
9 ..” any context in which the purpose of the evaluation is to determine the absolute functional level (IQ or Memory) of the examinee relative to a representative sample of the U.S. population” (The Psychological Corporation, 2002).
16Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
31 | Copyright © 2013. All rights reserved.
PremorbidPremorbid FunctionFunction• Software applies a regression equation to
predict premorbid abilities using demographic characteristics and/or performance on the ACS Test of PremorbidFunctioning (TOPF).
• Software Provides – Estimate of Premorbid IQ (FSIQ, GAI, VCI, PRI,
WMI, and PSI)
– Estimate of Premorbid Memory Ability (IMI, DMI, and VWMI)
32 | Copyright © 2013. All rights reserved.
Reliable ChangeReliable Change
• Assesses whether performance differences over time are due to actual changes in functioning, and not to the unreliability of the measure.
• Uses scores from the WAIS–IV and/or WMS–IV to compute a reliable change score between an assessment at Time 1 and Time 2.
17Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
33 | Copyright © 2013. All rights reserved.
Reliable ChangeReliable Change
• Software uses regression based models to provide an indicator of a significant decline in performance between test sessions controlling for the impact of practice effects, ability level, and age where appropriate.
• Available for all WAIS-IV and WMS-IV subtest and index scores.
34 | Copyright © 2013. All rights reserved.
Additional Subtest ScoresAdditional Subtest Scores
Allow better identification and description of the nature and extent of observed memory problems.
Additional WAIS-IV Subtest ScoresʊCancellation
Additional WMS-IV Subtest ScoresʊLogical MemoryʊVerbal Paired AssociatesʊDesignsʊVisual Reproduction
18Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
35 | Copyright © 2013. All rights reserved.
Additional Index ScoresAdditional Index Scores
WMS-IV Indexes– Auditory Immediate– Auditory Delayed– Auditory Recognition– Visual Immediate– Visual Delayed– Visual Recognition– Designs Spatial – Designs Content
36 | Copyright © 2013. All rights reserved.
Additional WMSAdditional WMS--IV Contrast ScoresIV Contrast Scores
AuditoryAuditoryɔ Immediate vs.
Delayed
ɔ Recognition vs. Delayed
VisualVisualɔ Immediate vs.
Delayed
ɔ Recognition vs. Delayed
Designs: Spatial vs. Content
19Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
37 | Copyright © 2013. All rights reserved.
SummarySummaryACS: Construct CoverageACS: Construct Coverage
Refined assessment of memory functions– Error scores– Additional indexes
Suboptimal Effort- Word Choice
- Embedded Measures
Social Cognition– Affect Recognition, Prosody
– Faces– Names
Executive Function– Trail-Making
– Verbal Fluency
Change in cognitive function
– Demographic Adjustments to Norms
– Premorbid Ability estimation
– Reliable Change Scores (regression based)
Are Cognitive Abilities Declining?
20Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
39 | Copyright © 2013. All rights reserved.
Many Factors can Influence Many Factors can Influence PerformancePerformance
– Acuity– Attention– Executive Functioning– Global Intellectual Functioning– Working Memory– Language Impairment (Auditory Memory subtests)– Visual-Spatial Processing (Visual Memory subtests)– Fatigue– Poor Effort– Impulsivity
40 | Copyright © 2013. All rights reserved.
Intake InformationIntake Information
• Mabel is an 82-year old female.
• She attended college but did not complete degree.
• She was married for 50 years until her husband died 10 years ago.
• She was a homemaker and never worked outside the home.
21Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
41 | Copyright © 2013. All rights reserved.
Referral ConcernsReferral Concerns
• Her children referred Mabel for evaluation.
• They are concerned about declines in her cognitive abilities and about her living alone.
42 | Copyright © 2013. All rights reserved.
Referral ConcernsReferral Concerns
According to her children,
– Mabel evidences word retrieval difficulties, and difficulty sequencing complex information.
– She is forgetful and easily overwhelmed with instrumental daily activities.
22Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
43 | Copyright © 2013. All rights reserved.
Intake InformationIntake Information
• Mabel is relatively physically healthy.
• She was diagnosed with atrialfibrilation and osteoporosis - both being treated with medication.
• She takes Namenda to treat cognitive decline.
44 | Copyright © 2013. All rights reserved.
Dementia or Dementia or Mild Cognitive ImpairmentMild Cognitive Impairment
Clinical concepts concerning this referral:
– Change in cognitive status from a previous level
– Mental Status
– Memory impairment
– Self-care
– Depression
23Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
45 | Copyright © 2013. All rights reserved.
Clinical QuestionsClinical Questions
Is Mabel experiencing dementia?– Does she evidence deficits in two or more
areas of cognition?
– Does she manifest a decline in memory and other cognitive functions relative to premorbid cognitive ability?
If cognitive abilities are impaired, what is the impact on daily living?
46 | Copyright © 2013. All rights reserved.
Procedures UtilizedProcedures Utilized
– WAIS-IV– WMS-IV + Brief Cognitive Status Exam
– ACS: Additional Scores– ACS: Test of Premorbid Functioning
– Reliable Change Scores (Serial Assessment)– Texas Functional Living Scales
24Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
47 | Copyright © 2013. All rights reserved.
Evaluation ResultsEvaluation Results
i Mini Mental Status Exam = 19 (middle stage/moderate Alzheimer’s disease)
i BDI-II=1 (no indication of depression)
48 | Copyright © 2013. All rights reserved.
CompositeCompositeClinical Clinical MeanMean
Control Control MeanMean
MeanMeanDiff.Diff. pp valuevalue
Effect Effect SizeSize
VCI 86.2 103.0 16.84 <.01 1.04
PRI 85.8 101.5 15.72 <.01 1.01
WMI 84.3 100.9 16.66 <.01 1.12
PSI 76.6 102.6 26.06 <.01 1.70
FSIQ 81.2 102.0 20.87 <.01 1.25
WAISWAIS--IV: Probable Dementia of IV: Probable Dementia of AlzheimerAlzheimer’’s Types Type--MildMild
n = 44
25Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
49 | Copyright © 2013. All rights reserved.
CompositeCompositeClinical Clinical MeanMean
Control Control MeanMean
MeanMeanDiff.Diff. pp valuevalue
Effect Effect SizeSize
VCI 99.0 106.1 7.13 <.01 .49PRI 93.9 102.4 8.43 <.01 .61WMI 96.6 104.7 8.13 <.01 .54PSI 94.9 102.2 7.33 .05 .53FSIQ 94.8 104.8 10.00 <.01 .72
WAISWAIS--IV: IV: Mild Cognitive ImpairmentMild Cognitive Impairment
n = 53
50 | Copyright © 2013. All rights reserved.
Composite Score/ Index/Subtest Scaled Score
Composite Score/ Index/Subtest Scaled Score
Verbal Comprehension 98 Perceptual Reasoning 92
Similarities 11 Block Design 9Vocabulary 10 Matrix Reasoning 9
Information 8 Visual Puzzles 8
Working Memory 97 Processing Speed 74
Digit Span 10 Coding 6
Arithmetic 9 Symbol Search 4
Full Scale IQ = 89 General Ability Index = 95
WAISWAIS--IV ScoresIV Scores
26Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
51 | Copyright © 2013. All rights reserved.
IndexIndex--Level Level Discrepancy ComparisonsDiscrepancy Comparisons
ComparisonScore
1Score
2 Diff.
Critical Value
.05
SignificantDifference
Y / N
Base RateOverall Sample
VCI - PRI 98 92 6 9.75 N 32.5
VCI - WMI 98 97 1 8.82 N 48.1
VCI - PSI 98 74 24 9.75 Y 7
PRI - WMI 92 97 -5 10.99 N 37.1
PRI - PSI 92 74 18 11.75 Y 12.1
WMI - PSI 97 74 23 10.99 Y 7.3
FSIQ - GAI 89 95 -6 3.19 Y 12.4
52 | Copyright © 2013. All rights reserved.
PSI: WeaknessPSI: Weakness
Mabel’s ability to mentally process routine information rapidly without making errors is a weakness relative to her verbal reasoning and nonverbal reasoning abilities.
27Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
53 | Copyright © 2013. All rights reserved.
PSI: Functional ImplicationPSI: Functional Implication
A weakness in the speed of processing routine visual information may make the task of comprehending novel and/or non-routine information more time-consuming and difficult for Mabel.
54 | Copyright © 2013. All rights reserved.
PSI: Functional ImplicationPSI: Functional Implication
A weakness in simple visual scanning and tracking may leave her less time and mental energy for the complex task of understanding new material.
28Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
55 | Copyright © 2013. All rights reserved.
WMSWMS--IV: Probable Dementia of IV: Probable Dementia of AlzheimerAlzheimer’’s Types Type--MildMild
n = 48 (ages 65-89)
WMS-IV Index
Clinical Mean
Control Mean
MeanDiff. p value
Effect Size
AMI 68.5 107.1 38.60 <.01 2.24
VMI 69.7 102.5 32.85 <.01 2.00
IMI 71.7 107.4 35.71 <.01 2.16
DMI 63.6 104.6 40.98 <.01 2.39
GAI 86.9 110.4 23.57 <.01 1.64
56 | Copyright © 2013. All rights reserved.
WMS-IV Index
Clinical Mean
Control Mean
MeanDiff.
p value Effect Size
AMI 89.9 105.6 15.65 <.01 1.05
VMI 89.3 102.1 12.84 <.01 0.89
VWMI 91.6 107.2 15.54 <.01 1.22
IMI 90.8 105.8 15.00 <.01 1.09
DMI 87.5 103.5 16.00 <.01 1.01
GAI 97.2 106.9 9.73 <.01 0.78
WMSWMS--IV: IV: Mild Cognitive ImpairmentMild Cognitive Impairment
n = 50 (ages 55-84)
29Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
57 | Copyright © 2013. All rights reserved.
WMSWMS--IV Scores: BCSEIV Scores: BCSE
i Mabel’s global cognitive functioning, as measured by the BCSE, was in the Lowrange, compared to others, ages 70 to 90, with a similar educational background.
i This classification level represents 2–4% of cases within her age and education group.
58 | Copyright © 2013. All rights reserved.
WMSWMS--IV Scores: BCSEIV Scores: BCSE
Functioning in this range has a moderately high probability of being considered atypical, though not necessarily diagnostic.
30Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
59 | Copyright © 2013. All rights reserved.
Index/Subtest Index Score/ Scaled Score
Index/Subtest Index Score/ Scaled Score
Auditory Memory 78 Visual Memory 66
Logical Memory I 9 Visual Reproduction I 3Logical Memory II 2 Visual Reproduction II 5
Verbal Paired Associates I 7
Verbal Paired Associates II 7 Symbol Span 6
Immediate Memory 77 Delayed Memory 67
Logical Memory I 9 Logical Memory II 2
Verbal Paired Associates I 7 Verbal Paired Associates II 7
Visual Reproduction I 3 Visual Reproduction II 5
WMSWMS--IV ScoresIV Scores
60 | Copyright © 2013. All rights reserved.
AbilityAbility––Memory AnalysisMemory Analysis
Ability Score Type: GAI (= 95)Predicted Difference Method
Index
Predicted WMS–IV
Index Score
Actual WMS–IV
Index Score Difference
Critical Value
SignificantDifference
Y / NBaseRate
Auditory Memory 97 78 19 9.33 Y
5-10%
Visual Memory 97 66 31 7.72 Y <1%
Immediate Memory 97 77 20 10.41 Y 4%
Delayed Memory 97 67 30 10.86 Y 1%
31Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
61 | Copyright © 2013. All rights reserved.
Retention of InformationRetention of Information
WMS–IV Indexes
Index Score 1 Score 2Contrast
Scaled ScoreImmediate Memory Index vs. Delayed Memory Index
77 67 5
62 | Copyright © 2013. All rights reserved.
Auditory Memory Relative Auditory Memory Relative to WAISto WAIS--IV AbilitiesIV Abilities
Contrast Scaled Scores
Score Score 1 Score 2Contrast
Scaled Score
General Ability Index vs. Auditory Memory Index
95 78 5
Verbal Comprehension Index vs. Auditory Memory Index
98 78 5
Working Memory Index vs. Auditory Memory Index
97 78 6
32Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
63 | Copyright © 2013. All rights reserved.
GAI vs. AMIGAI vs. AMIThe clinical groups that significantly differ from the controls and have large effect sizes on the GAI vs. AMI are– Probable Dementia of the Alzheimer’s
Type-Mild Severity, – Mild Cognitive Impairment, – Mild and Moderate Intellectual Disability, – Schizophrenia, and – Moderate-to-Severe TBI groups.
64 | Copyright © 2013. All rights reserved.
Auditory Process ScoresAuditory Process Scores
Auditory Memory Process Score Summary
ScoreRaw
ScoreScaled Score
Percentile Rank
Cumulative Percentage(Base Rate)
LM II Recognition 15 - - 17-25%
VPA II Recognition 22 - - 10-16%
VPA II Word Recall 5 7 16 -
33Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
65 | Copyright © 2013. All rights reserved.
Forgetting and Retrieval: Forgetting and Retrieval: Auditory ModalityAuditory Modality
Logical Memory
Score Score 1 Score 2Contrast
Scaled Score
LM II Recognition vs. Delayed Recall 17-25% 2 1
LM Immediate Recall vs. Delayed Recall 9 2 1
66 | Copyright © 2013. All rights reserved.
Forgetting and Retrieval: Forgetting and Retrieval: Auditory ModalityAuditory Modality
Verbal Paired Associates
Score Score 1 Score 2Contrast
Scaled ScoreVPA II Recognition vs. Delayed Recall 10-16% 7 9
VPA Immediate Recall vs. Delayed Recall 7 7 10
34Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
67 | Copyright © 2013. All rights reserved.
Visual Memory Relative Visual Memory Relative to Other Abilitiesto Other Abilities
Score Score 1 Score 2Contrast
Scaled Score
General Ability Index vs. Visual Memory Index
95 66 2
Perceptual Reasoning Index vs. Visual Memory Index
92 66 2
68 | Copyright © 2013. All rights reserved.
Visual Process ScoresVisual Process Scores
Visual Memory Process Score Summary
ScoreRaw
ScoreScaled Score
Percentile Rank
Cumulative Percentage(Base Rate)
VR II Recognition 2 - - 17-25%
VR II Copy 43 - - >75%
35Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
69 | Copyright © 2013. All rights reserved.
Forgetting and Retrieval: Forgetting and Retrieval: Visual ModalityVisual Modality
Visual Reproduction
Score Score 1 Score 2Contrast
Scaled Score
VR II Recognition vs. Delayed Recall
17-25% 5 6
VR Copy vs. Immediate Recall
>75% 3 2
VR Immediate Recall vs. Delayed Recall
3 5 8
70 | Copyright © 2013. All rights reserved.
ModalityModality--Specific Memory Specific Memory Strengths and WeaknessesStrengths and Weaknesses
WMS–IV Indexes
Index Score 1 Score 2Contrast
Scaled ScoreAuditory Memory Index vs. Visual Memory Index 78 66 5
36Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
71 | Copyright © 2013. All rights reserved.
Visual Working MemoryVisual Working Memory
Mabel’s ability to keep in mind a mental image of a symbol and its relative spatial position on the page is below average (Symbol Span scaled score = 6).
72 | Copyright © 2013. All rights reserved.
Immediate Memory Relative Immediate Memory Relative to WAISto WAIS--IV GAIIV GAI
Score Score 1 Score 2Contrast
Scaled Score
General Ability Index vs. Immediate Memory Index
95 77 4
37Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
73 | Copyright © 2013. All rights reserved.
GAI vs. IMIGAI vs. IMIThe clinical groups that significantly differ from the controls and have large effect sizes on the GAI vs. IMI are– Probable Dementia of the Alzheimer’s
Type-Mild Severity, – Mild Cognitive Impairment, – Mild and Moderate Intellectual Disability, – Right Temporal Lobectomy, – Moderate-to-Severe TBI groups, and– Autistic Disorder groups.
74 | Copyright © 2013. All rights reserved.
Delayed Memory Relative Delayed Memory Relative to WAISto WAIS--IV GAIIV GAI
ScoreScore
1Score
2Contrast
Scaled Score
General Ability Index vs. Delayed Memory Index
95 67 3
38Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
75 | Copyright © 2013. All rights reserved.
GAI vs. DMIGAI vs. DMI
The clinical groups that significantly differ from the controls and have large effect sizes on the GAI vs. DMI are– Probable Dementia of the Alzheimer’s
Type-Mild Severity, – Mild Cognitive Impairment, – Mild and Moderate Intellectual Disability, – Right Temporal Lobectomy, – Autistic Disorder, Schizophrenia, and – Moderate-to-Severe TBI groups.
76 | Copyright © 2013. All rights reserved.
Additional ScoresAdditional Scores--AMIAMI
WMS-IV Index
Index Score
Percentile Rank
Qualitative Description
Auditory Immediate 89 23 Low Average
Auditory Delayed 67 1 Extremely Low
Auditory Recognition 76 5 Borderline
39Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
77 | Copyright © 2013. All rights reserved.
Additional ScoresAdditional Scores--AMIAMI
Score Score 1 Score 2
Contrast Scaled Score
Auditory Immediate Index vs. Auditory Delayed Memory Index
89 67 1
Auditory Recognition Index vs. Auditory Delayed Memory Index
76 67 5
78 | Copyright © 2013. All rights reserved.
Test of Test of PremorbidPremorbid FunctioningFunctioning
• Uses Atypical Grapheme-Phoneme translation to measure word knowledge through reading.
• Relatively resistant to brain injury and dementia.
40Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
79 | Copyright © 2013. All rights reserved.
Test of Test of PremorbidPremorbid FunctioningFunctioning
• Premorbid Prediction Models– Demographics only (simple or
complex)
– TOPF only– Demographics with TOPF
• Predict WAIS-IV Indexes and WMS-IV IMI, DMI, and VWMI
80 | Copyright © 2013. All rights reserved.
PremorbidPremorbid FunctioningFunctioning
Test of Premorbid Functioning Score Summary
Raw Score
Standard Score
Percentile Rank
Qualitative Description
Test of PremorbidFunctioning 61 119 89.7 High Average
41Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
81 | Copyright © 2013. All rights reserved.
PremorbidPremorbid FunctioningFunctioning
WAISWAIS––IV Actual IV Actual –– Predicted ComparisonPredicted Comparison
Composite Actual Equated DifferenceCritical Value
Significant Difference
Base Rate
FSIQ 89 117 -28 6.11 Y 3.4%
VCI 98 117 -19 7.3 Y 9.3%
PRI 92 117 -25 11.12 Y 17.9%
WMI 97 118 -21 9.77 Y 16.1%
PSI 74 118 -44 11.04 Y 5.7%
Actual – Predicted Comparison based on Test of Premorbid Functioning Equated Model
82 | Copyright © 2013. All rights reserved.
PremorbidPremorbid FunctioningFunctioning
WMS–IV Actual – Predicted Comparison
Index Actual Equated DifferenceCritical Value
Significant Difference
Base Rate
IMI 77 117 -40 9.65 Y 2.2%
DMI 67 118 -51 10.36 Y 3.9%
Actual – Predicted Comparison based on Test of Premorbid Functioning Equated Model
42Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
83 | Copyright © 2013. All rights reserved.
Reliable Change ScoreReliable Change Score
Used to determine if there has been a change in cognitive functioning between 2 time periods– Decline associated with dementia or other
progressive neurological condition– Improved function related to intervention
such as rehabilitation or medication effects
84 | Copyright © 2013. All rights reserved.
Reliable Change ScoreReliable Change Score
Applies multivariate hierarchical regression method to control for practice effects and other factors associated with change in performance.
43Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
85 | Copyright © 2013. All rights reserved.
Reliable Change ScoreReliable Change Score
Predictors– Time 1 performance
– GAI (or VCI or PRI)
– Age
– Education
– Sex
– Test interval
86 | Copyright © 2013. All rights reserved.
Reliable Change ScoreReliable Change Score
• Compare actual time 2 performance to predicted time 2 performance
– Statistically significant difference
– Base rate
• If difference is significant and rare, may indicate a decline or improvement in functioning.
44Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
87 | Copyright © 2013. All rights reserved.
Reliable Change ScoreReliable Change Score
Serial Assessment Report for WAIS-IV and WMS-IV Mabel Sample82
Test-Retest Interval 6 months 0 days
88 | Copyright © 2013. All rights reserved.
WAISWAIS--IV Serial AssessmentIV Serial Assessment
45Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
89 | Copyright © 2013. All rights reserved.
WMSWMS--IV Serial AssessmentIV Serial Assessment
90 | Copyright © 2013. All rights reserved.
Clinical QuestionsClinical Questions
Is Mabel experiencing dementia?
– Progressive and long-term decline in cognitive function.
– Perceptual reasoning ability, speed of processing visual information, and memory, especially long-term memory.
46Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
91 | Copyright © 2013. All rights reserved.
Diagnosis and TreatmentDiagnosis and Treatment
• Evaluate all data to determine if Mabel’s current functioning is consistent with a diagnosis of Dementia.
• Establish the impact of cognitive impairment on Mabel’s performance of instrumental activities of daily living?
92 | Copyright © 2013. All rights reserved.
Instrumental Activities of Instrumental Activities of Daily LivingDaily Living
Texas Functional Living Scale
ScoreTime Total
Money and Calculation
TotalCommunication
TotalMemory
TotalTFLS Total
Raw Score 8 6 26 3 43
Subscale Cumulative Percentage
51-75 17-25 26-50 3-9
TFLS T-Score 40
47Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
93 | Copyright © 2013. All rights reserved.
Instrumental Activities of Instrumental Activities of Daily LivingDaily Living
• Impairments in cognitive functions adversely impact Mabel’s ability to perform instrumental activities of daily living.
• T-score of 40 on the TFLS indicates mild impairment.
94 | Copyright © 2013. All rights reserved.
DiagnosisDiagnosis
• On initial assessment, Mabel’s performance indicated a possible decline in functioning from previous levels of performance with a clear memory impairment present.
• On re-evaluation, Mabel showed significant declines in general intellectual and memory functioning.
48Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
95 | Copyright © 2013. All rights reserved.
DiagnosisDiagnosis
• The data indicate a progressive and long-term decline in cognitive function.
• The clinician diagnosed Mabel with Alzheimer’s Disease.
96 | Copyright © 2013. All rights reserved.
Living ArrangementsLiving Arrangements
• It was determined that Mabel required an assisted living environment due to her significant difficulties with memory and daily functioning.
• Mabel was placed in an assisted living facility close to her children. She functioned relatively independently and did well with structured routines.
49Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
97 | Copyright © 2013. All rights reserved.
Interventions: EncodingInterventions: Encoding
• Given her relative strength in higher-order conceptualization and reasoning, Mabel may benefit from using associative linkages when encoding information.
• By linking new information to what has been previously learned, she may be able to gain a more global understanding of the information and improve recall.
98 | Copyright © 2013. All rights reserved.
Interventions: EncodingInterventions: Encoding
• When she first encounters new information, she should link it in as many ways as possible to already known information.
• This strategy creates several avenues for remembering the information later.
50Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
99 | Copyright © 2013. All rights reserved.
Interventions: EncodingInterventions: Encoding
• Encourage her to use external memory sources, for example, leaving verbal messages on her telephone answering machine, to remind herself to pay bills, take medication, schedule/keep appointments, etc.
100 | Copyright © 2013. All rights reserved.
Interventions: Interventions: Retention of InformationRetention of Information
To increase her ability to retain information, build on her relative strength in verbal comprehension.– Encourage her to verbalize the steps she
will use to complete a daily routine (e.g., dressing) or to complete an assigned task. This self-talk can reinforce the sequencing of all necessary steps for successful task completion.
51Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
101 | Copyright © 2013. All rights reserved.
Interventions: Interventions: Retention of InformationRetention of Information
To increase her ability to retain information, build on her relative strength in verbal comprehension.
– To complete extensive or complex tasks, ask her to break down these larger tasks into shorter, simpler tasks with feasible deadlines.
102 | Copyright © 2013. All rights reserved.
Interventions to Improve SkillsInterventions to Improve Skills
Her short-term memory and vocabulary skills could be improved at home while playing games that require memory, concentration, and recall of information.
52Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
103 | Copyright © 2013. All rights reserved.
Interventions to Improve SkillsInterventions to Improve Skills
• Computer-assisted educational programs may be of benefit to her.
• If she enjoys video games, learning can be integrated into this fun activity.
• Numerous commercial educational software packages exist to meet her needs.
Is Performance Consistent with the Nature of the Injury
or Clinical Condition?
53Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
105 | Copyright © 2013. All rights reserved.
Background InformationBackground Information
• Blake is a 23 year old, single, white male, with a bachelor’s degree in political science.
• In 2009, he was working as an assistant store manager when he sustained a moderate TBI as a result of a motor vehicle accident.
• Upon admission to the hospital, his Glasgow Coma Scale was 7.
106 | Copyright © 2013. All rights reserved.
Background InformationBackground Information
• He sustained hemorrhagic contusions with depressed skull fracture in right frontal area.
• Blood was noted in anterior temporal tip.
54Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
107 | Copyright © 2013. All rights reserved.
Frontal LobeFrontal Lobe
Damage associated primarily with executive dysfunction – possible impaired flexibility in problem-solving or in adaptability (Lezak, et al., 2004).
http://www.neuroskills.com/tbi/bfrontal.shtml
108 | Copyright © 2013. All rights reserved.
Background InformationBackground Information
• Blake’s orientation and language functions returned to normal after 3㵥4 hours.
• He experienced on㵥going headaches, sleepiness, and fatigue for several days.
• He was released from the hospital after 3 days.
55Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
109 | Copyright © 2013. All rights reserved.
Background InformationBackground Information
• Blake continued to struggle with fatigue.
• He struggled to concentrate especially when reading.
• He returned to work after 3 weeks but had to leave early because of headaches and difficulty focusing and sustaining his attention.
110 | Copyright © 2013. All rights reserved.
Background InformationBackground Information
• His parents encouraged Blake to seek legal counsel regarding the accident because the accident had been caused by a car whose driver had failed to stop at the red light.
• The lawyer observed that they had a good chance of winning a claim against the company given the on-going difficulties Blake was experiencing after the accident.
56Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
111 | Copyright © 2013. All rights reserved.
Background InformationBackground Information
• As part of the legal case, Blake was sent for neuropsychological evaluation of ongoing attention problems.
• The evaluation was conducted 12 months post㵥injury.
112 | Copyright © 2013. All rights reserved.
Traumatic Brain InjuryTraumatic Brain Injury
– Acquired brain injury caused by external physical force
– May lead to temporary or permanent impairment of
� cognitive,
� physical, and
� psychosocial functions.
http://emedicine.medscape.com/article/326510-overview
57Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
113 | Copyright © 2013. All rights reserved.
Moderate TBIModerate TBI––Clinical ConceptsClinical ConceptsTBI associated with deficits in– memory (including working memory)– attention/executive functioning– processing speed– theory of mind and social perception (more
recently)– language problems – perceptual problems
See TBI special group studies in WAIS-IV and WMS-IV Technical and interpretive manual.
114 | Copyright © 2013. All rights reserved.
Moderate TBIModerate TBI––Clinical ConceptsClinical Concepts
• Higher-level cognitive skills, commonly referred to as executive functions, have been ascribed primarily to dorsolateralprefrontal regions.
• Emotional and behavioral regulation and control have been attributed primarily to ventromedial prefrontal cortex.
58Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
115 | Copyright © 2013. All rights reserved.
Moderate TBIModerate TBI––Clinical ConceptsClinical Concepts
• Loss of cognitive functioning from a previous level.
• Secondary gain introduced by the medical㵥legal case against the company responsible for the accident.
• Medical evidence for the presence of a moderate TBI.
116 | Copyright © 2013. All rights reserved.
Procedures UtilizedProcedures Utilized
– Record Review
– Clinical Interview
– WAIS㵥IV
– WMS㵥IV
– ACS: Demographically Adjusted Norms
– D㵥KEFS: Trail Making, Verbal Fluency
– ACS: Social Perception
– ACS: Suboptimal Effort
59Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
117 | Copyright © 2013. All rights reserved.
Moderate TBI and CognitionModerate TBI and Cognition
• Is there evidence of impairment in general cognitive functioning?
• Is there evidence of a deficit in memory?
118 | Copyright © 2013. All rights reserved.
TBI and WAISTBI and WAIS--IVIV
n = 22
CompositeCompositeClinical Clinical MeanMean
Control Control MeanMean
MeanMeanDiff.Diff.
ppvaluevalue
Effect Effect SizeSize
VCI 92.1 100.8 8.73 .03 .52
PRI 86.1 100.7 14.64 <.01 .94
WMI 85.3 97.9 12.59 <.01 .78
PSI 80.5 97.6 17.09 <.01 .97
FSIQ 83.9 99.4 15.50 <.01 .93
60Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
119 | Copyright © 2013. All rights reserved.
Composite Score/ Index/Subtest Scaled Score
Composite Score/ Index/Subtest Scaled Score
Verbal Comprehension 114 Perceptual Reasoning 98
Similarities 13 Block Design 10
Vocabulary 13 Matrix Reasoning 9
Information 12 Visual Puzzles 10
Working Memory 100 Processing Speed 102
Digit Span 10 Coding 10
Arithmetic 10 Symbol Search 11
Full Scale IQ = 105 General Ability Index = 106
WAISWAIS--IV ScoresIV Scores
120 | Copyright © 2013. All rights reserved.
IndexIndex--Level Discrepancy Level Discrepancy ComparisonsComparisons
Comparison Score 1 Score 2 DifferenceCritical
Value .05
SignificantDifference
Y / N
Base RateOverall Sample
VCI - PRI 114 98 16 9.29 Y 12.2
VCI - WMI 114 100 14 10.18 Y 14.1
VCI - PSI 114 102 12 10.99 Y 22.2
PRI - WMI 98 100 -2 10.99 N --
PRI - PSI 98 102 -4 11.75 N --
WMI - PSI 100 102 -2 12.46 N --
FSIQ - GAI 105 106 -1 3.5 N --
61Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
121 | Copyright © 2013. All rights reserved.
What is the GAI?What is the GAI?
• The WAIS–IV GAI provides the practitioner with a summary score that is less sensitive than the FSIQ to the influence of working memory and processing speed.
• GAI = sum of scaled scores for VCI subtests and PRI subtests.
122 | Copyright © 2013. All rights reserved.
What is the GAI?What is the GAI?
• WAIS–IV GAI should be used for discrepancy comparisons
– Ability and Memory
– Ability and achievement
• GAI is NOT a replacement for FSIQ
62Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
123 | Copyright © 2013. All rights reserved.
General Ability IndexGeneral Ability IndexConsider*Consider* using the GAI if a significant and unusual discrepancy exists between
9 VCI and WMI; or 9 PRI and PSI; or9 WMI and PSI, or9 between subtests within WMI and/or PSI.
Note: The FSIQ is the most valid measure of overall cognitive ability and WM and PS are vital to comprehensive evaluation of cognitive ability.
124 | Copyright © 2013. All rights reserved.
General Ability Index General Ability Index -- Note!Note!• The GAI is used when neuropsychological deficits
adversely impact performance on WM and PS.
• Impaired performance on WM and/or PS may mask actual differences between general cognitive ability (FSIQ) and other cognitive functions (e.g., memory).
• The GAI does not replace the FSIQ. Report and interpret GAI along with FSIQ.
[see WAIS-IV Technical Manual]
63Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
125 | Copyright © 2013. All rights reserved.
Moderate TBI and Ability (WAISModerate TBI and Ability (WAIS--IV)IV)
• Relative to others his age, Blake’s intellectual functioning is within the Average range.
• Verbal comprehension is a strength relative to perceptual reasoning, working memory, and processing speed.
126 | Copyright © 2013. All rights reserved.
TBI and WMSTBI and WMS--IVIV n = 32 (ages 19n = 32 (ages 19--45)45)
IndexIndexClinical Clinical MeanMean
Control Control MeanMean
MeanMeanDiff.Diff.
ppvaluevalue
Effect Effect SizeSize
AMI 80.0 101.0 21.00 <.01 1.25
VMI 82.5 101.2 18.64 <.01 1.07
VWMI 85.5 104.6 19.06 <.01 1.26
IMI 80.7 102.2 21.53 <.01 1.24
DMI 77.8 100.4 22.64 <.01 1.24
GAI 92.2 104.8 12.65 <.01 .92
64Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
127 | Copyright © 2013. All rights reserved.
Index Score/ Index/Subtest Scaled Score
Index Score/ Index/Subtest Scaled Score
Auditory Memory 105 Visual Memory 96
Logical Memory I 13 Visual Reproduction 10
Logical Memory II 16(S) Visual Reproduction II 10
Verbal Paired Associates I 7(W) Designs I 8
Verbal Paired Associates II 8(W) Designs II 10
Visual Working Memory 100
Spatial Addition 12
Symbol Span 8
WMSWMS--IV ScoresIV Scores
128 | Copyright © 2013. All rights reserved.
Index Score/ Index/Subtest Scaled Score
Index Score/ Index/Subtest Scaled Score
Immediate Memory 96 Delayed Memory 107
Logical Memory I 13 Logical Memory II 16
Verbal Paired Associates I 7 Verbal Paired Associates II 8
Visual Reproduction I 10 Visual Reproduction II 10
WMSWMS--IV ScoresIV Scores
65Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
129 | Copyright © 2013. All rights reserved.
Moderate TBI and MemoryModerate TBI and Memory
• On WMS-IV, all index scores are in the average range.
• Delayed memory is a strength relative to Immediate Memory (contrast scaled score = 14).
• Scores on memory indexes are average relative to general ability.
• Note relative weakness for VPA I and VPA II and relative strength for LM II.
130 | Copyright © 2013. All rights reserved.
AbilityAbility––Memory AnalysisMemory Analysis
Predicted Difference Method: GAI = 106Predicted Difference Method: GAI = 106
IndexIndex
Predicted Predicted WMSWMS--IV IV
Index ScoreIndex Score
Actual Actual WMSWMS––IV IV
Index ScoreIndex Score Diff. Diff. Critical Critical ValueValue
Sign. Sign. Diff. Diff. Y / NY / N
BaseBaseRateRate
AMI 103 105 -2 9.35 N --
VMI 104 96 8 8.95 N --
VWMI 104 100 4 10.61 N --
IMI 104 96 8 9.78 N --
DMI 103 107 -4 9.57 N --
66Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
131 | Copyright © 2013. All rights reserved.
Moderate TBIModerate TBI
• Is this profile atypical for Blake’s education level?
• Is there evidence for loss of cognitive functioning.
Use Demographically Adjusted Norms
132 | Copyright © 2013. All rights reserved.
Demographically Adjusted NormsDemographically Adjusted Norms
• Enable clinician to refine hypothesis about the degree to which a specific score is unexpected when compared to individuals of similar background characteristics (e.g., education level).
• Norms approximate the unique demographic subgroup of an individual.
67Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
133 | Copyright © 2013. All rights reserved.
Demographically Adjusted NormsDemographically Adjusted Norms
Available for WAIS-IV and WMS-IV subtest and index scores.– Education-only adjusted t-scores.
– Full Demographically adjusted t-scores.
134 | Copyright © 2013. All rights reserved.
Use of Demographically Use of Demographically Adjusted NormsAdjusted Norms
• Meant to minimize the impact of psychosocial variables on the diagnosis of cognitive impairment, such as estimating the degree of cognitive impairment after a brain injury or insult.
• “ . . . most appropriately applied in the context of a neuro-diagnostic assessment.”
68Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
135 | Copyright © 2013. All rights reserved.
WAISWAIS--IV DANIV DAN
WAIS-IV Education Adjusted Composite Score Summary
Age AdjustedAge Adjusted Education AdjustedEducation Adjusted
CompositeCompositeComposite Composite
ScoreScorePercentile Percentile
RankRank T Score T Score Percentile Percentile
RankRankQualitative Qualitative DescriptionDescription
VCI 114 82 55 69.1Above
Average
PRI 98 45 44 27.4 Low Average
WMI 100 50 45 30.9 Average
PSI 102 55 48 42.1 Average
FSIQ 105 63 48 42.1 Average
GAI 106 66 49 46.0 Average
WAISWAIS--IV DANIV DANWAIS–IV Education Adjusted Subtest Score Summary
Age Adjusted Education Adjusted
Subtest Scaled Score
PercentileRank
T Score
PercentileRank
Qualitative Description
Similarities 13 84 57 75.8 Above Average
Vocabulary 13 84 55 69.1 Above Average
Information 12 75 52 57.9 Average
Block Design 10 50 47 38.2 Average
Matrix Reasoning 9 37 43 24.2 Low Average
Visual Puzzles 10 50 49 46.0 Average
Digit Span 10 50 47 38.2 Average
Arithmetic 10 50 46 34.5 Average
Symbol Search 11 63 50 50.0 Average
Coding 10 50 47 38.2 Average
136 | Copyright © 2013. All rights reserved.
69Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
137 | Copyright © 2013. All rights reserved.
WMSWMS--IV DANIV DAN
WMS-IV Education Adjusted Index Score Summary
Age AdjustedAge Adjusted Education AdjustedEducation Adjusted
IndexIndexIndex Index ScoreScore
Percentile Percentile RankRank T Score T Score
Percentile Percentile RankRank
Qualitative Qualitative DescriptionDescription
AMI 105 63 52 57.9 Average
VMI 96 39 45 30.9 Average
VWMI 100 50 47 38.2 Average
IMI 96 39 44 27.4 Low Average
DMI 107 68 52 57.9 Average
WMSWMS--IV DANIV DAN
WMS–IV Education Adjusted Subtest Score Summary
Age Adjusted Education Adjusted
Subtest Scaled Score PR
T Score PR
Qualitative Description
Logical Memory I 13 84 58 78.8 Above Average
Logical Memory II 16 98 69 97.1 Above Average
Verbal Paired Associates I 7 16 38 11.5 Mild Impairment
Verbal Paired Associates II 8 25 41 18.4 Low Average
Designs I 8 25 41 18.4 Low Average
Designs II 10 50 49 46.0 Average
Visual Reproduction I 10 50 48 42.1 Average
Visual Reproduction II 10 50 48 42.1 Average
Spatial Addition 12 75 54 65.5 Average
Symbol Span 8 25 42 21.2 Low Average
138 | Copyright © 2013. All rights reserved.
70Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
139 | Copyright © 2013. All rights reserved.
What do we know about Moderate to What do we know about Moderate to Severe TBI and WAISSevere TBI and WAIS--IV/WMSIV/WMS--IV/ACSIV/ACS
Executive FunctioningD-KEFS Trail Making Test
Ɇ Trail Making Letter and Number Sequencing 6.5
Ɇ Number-Letter Switching Time 7.1Ɇ Number-Letter Switching Errors 11.0
Also see Yochim, B., Baldo, J., Nelson, A., & Delis, D. (Jul 2007). D-KEFS trail
making test performance in patients with lateral prefrontal cortex lesions. Journal of the International Neuropsychological Society, 13(4), 704-709.
140 | Copyright © 2013. All rights reserved.
Trail MakingTrail Making
D-KEFS Trail Making - BlakeɆ Visual Scanning SS = 10Ɇ Number Sequencing SS = 7Ɇ Letter Sequencing SS = 8Ɇ Number-Letter Switching SS = 6Ɇ Number-Letter Switching Errors SS = 10Ɇ Motor Planning SS = 9
71Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
141 | Copyright © 2013. All rights reserved.
What do we know about Moderate to What do we know about Moderate to Severe TBI and WAISSevere TBI and WAIS--IV/WMSIV/WMS--IV/ACSIV/ACS
• Executive FunctioningD-KEFS Verbal Fluency
Ɇ Letter Fluency 7.6Ɇ Category Fluency 6.7Ɇ Category Switching Total Correct 7.0Ɇ Category Switching Total Accuracy 8.1
142 | Copyright © 2013. All rights reserved.
Verbal FluencyVerbal Fluency
D-KEFS Verbal Fluency - BlakeɆ Letter Fluency SS = 11Ɇ Category Fluency SS = 9Ɇ Category Switching SS = 8Ɇ Category Switching Accuracy SS = 8Ɇ Set Loss Error SS = 10Ɇ Repetitions SS = 9
72Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
143 | Copyright © 2013. All rights reserved.
Moderate TBI Moderate TBI –– Executive Executive FunctioningFunctioning
Are there deficits in executive functioning?Ɇ Trail Making: low-average scores for number
sequencing and switching.Ɇ Cannot determine if the problem is executive
functioning or slow processing speed.
Ɇ Verbal Fluency: scores in the average range.
144 | Copyright © 2013. All rights reserved.
Moderate TBI Moderate TBI –– Social PerceptionSocial Perception
Is there a deficit in social perception?
Social Perception has 3 tasks:– Affect Naming (Happy, Sad, Angry,
Surprise, Disgust, Fear, and Neutral)
– Prosody㵥Face Matching (includes Sarcasm)
– Prosody㵥Pairs Matching
73Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
145 | Copyright © 2013. All rights reserved.
What do we know about Moderate to Severe What do we know about Moderate to Severe TBI and WAISTBI and WAIS--IV/WMSIV/WMS--IV/ACSIV/ACS
Holdnack & Drozdick (2009). Social Perception Deficits after Moderate to Severe Traumatic Brain Injury. www.psychcorp.com
146 | Copyright © 2013. All rights reserved.
Moderate TBI Moderate TBI –– Social PerceptionSocial PerceptionIs there a deficit in social perception?– Scores range from low average to average
with 3 of 4 scores at 1sd below mean.– Compared to intellectual functioning,
social perception scores were low average.
– Observationally, he made errors mostly on incongruent items, particularly sarcasm.
74Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
147 | Copyright © 2013. All rights reserved.
Symptom Exaggeration?Symptom Exaggeration?
• What if the test results were exaggerated in order to gain an advantage in the law suit?
• Use ACS effort assessment to help determine if suboptimal effort issues should be considered.
148 | Copyright © 2013. All rights reserved.
Suboptimal EffortSuboptimal Effort
Criteria for definite malingering, neuro-cognitive deficit:– Presence of substantial external
incentive,– Definitive negative response bias, and– The response bias is not accounted for by
psychiatric, neurological, or developmental factors (Slick, Sherman, and Iverson, 1999).
75Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
149 | Copyright © 2013. All rights reserved.
Assessing Suboptimal EffortAssessing Suboptimal Effort
• ACS Word Choice• WAIS㵥IV Reliable Digit Span• WMS㵥IV– Logical Memory Delayed Recognition– Verbal Paired Associates Delayed Recognition– Visual Reproduction Delayed Recognition
[Available for ages 16㵥69]
150 | Copyright © 2013. All rights reserved.
Word ChoiceWord Choice1. Examinee sees and hears 50 words in
succession.
2. Examinee identifies each word as either man-made or natural.
3. Examinee sees card with 50 pairs of words and selects word that was previously presented from each pair.
76Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
151 | Copyright © 2013. All rights reserved.
Suboptimal EffortSuboptimal Effort
• Use at least 3 indicators.• Require at least 2 indicators at or below
cut㵥off when using low cut㵥offs (e.g. 10%).
See Effort Assessment Score Report Blake Sample 23.
152 | Copyright © 2013. All rights reserved.
Moderate TBI Moderate TBI -- ConclusionsConclusions
• Is this protocol indicative of suboptimal effort? No
• Overall conclusions– Blake suffered a moderate/severe TBI as
documented by medical records.
– Relative to his verbal comprehension abilities, he demonstrated a weakness on measures of perceptual reasoning, working memory, and processing speed.
77Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
153 | Copyright © 2013. All rights reserved.
Moderate TBI Moderate TBI -- ConclusionsConclusions
• Overall conclusions– His memory abilities are average
compared to his general ability.
– Interpretation of Blake’s performance on the Auditory Memory index should account for the variability of the subtest scores.
154 | Copyright © 2013. All rights reserved.
AMI AMI –– Score VariabilityScore VariabilityThe clinical relevance of the score variability on the AMI should be addressed in terms of Blake’s
– premorbid abilities,
– demands in his current environment,
– other co㵥occurring physical factors (e.g., recent onset of auditory acuity difficulties or physical impairments), or
– emotional status (e.g., depression, anxiety).
78Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
155 | Copyright © 2013. All rights reserved.
Moderate Moderate –– TBI ConclusionsTBI Conclusions
Overall conclusions– Acquired brain injury as a result of a MVA.
– Demonstrated weaknesses in switching mental set (executive function) and in social perception. These characteristics are consistent with known effects of brain injury.� Frontal lobe damage can impair cognitive flexibility.
� Injury to anterior temporal region can produce deficits in affect labeling, recognition of emotion, theory of mind.
156 | Copyright © 2013. All rights reserved.
RecommendationsRecommendations• It may be necessary to give Blake very specific
routines for work completion. For example, he should be told where to put materials, what to do if he does not understand the assignment, and what to do with the assignment once complete.
• Blake should be set well-defined time limits for task completion, so that tasks are completed in a timely manner. Blake should be allowed to monitor his own progress with a timing device.
79Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
157 | Copyright © 2013. All rights reserved.
RecommendationsRecommendations
• Blake should be taught to use a problem-solving approach to behavioral situations. Steps should involve Blake determining the best possible option for his behavior, choosing a problem-solving strategy, and evaluating the outcome.
• Concrete examples should be used to teach the approach (e.g., “What should you do if you are trying to concentrate on your work and another person begins talking to you?”).
158 | Copyright © 2013. All rights reserved.
www.acsw4w4.comwww.psychcorp.com
Comments or QuestionsComments or [email protected]
For More Information . . .
80Copyright © 2013. Pearson, Inc., and/or its affiliates. All rights reserved.
Advanced Clinical Solutions: Enhancing the Clinical Utility of WAIS-IV and WMS-IVGloria Maccow, Ph.D., Assessment Training Consultant
Customer ServiceCustomer Service11--800800--627627--72717271
Questions or CommentsQuestions or [email protected]@pearson.com